These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 10837059)
1. Dendritic cells in cancer immunotherapy. Fong L; Engleman EG Annu Rev Immunol; 2000; 18():245-73. PubMed ID: 10837059 [TBL] [Abstract][Full Text] [Related]
2. Dendritic cells (II): Role and therapeutic implications in cancer. Satthaporn S; Eremin O J R Coll Surg Edinb; 2001 Jun; 46(3):159-67. PubMed ID: 11478013 [TBL] [Abstract][Full Text] [Related]
3. RNA pulsed dendritic cells: an approach for cancer immunotherapy. Garg NK; Dwivedi P; Prabha P; Tyagi RK Vaccine; 2013 Feb; 31(8):1141-56. PubMed ID: 23306369 [TBL] [Abstract][Full Text] [Related]
4. RNA-based immunotherapy of cancer: role and therapeutic implications of dendritic cells. Tyagi RK; Mangal S; Garg N; Sharma PK Expert Rev Anticancer Ther; 2009 Jan; 9(1):97-114. PubMed ID: 19105710 [TBL] [Abstract][Full Text] [Related]
5. Dendritic cell vaccines for cancer immunotherapy. Timmerman JM; Levy R Annu Rev Med; 1999; 50():507-29. PubMed ID: 10073291 [TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-based treatment of cancer: closing in on a cellular therapy. Valone FH; Small E; MacKenzie M; Burch P; Lacy M; Peshwa MV; Laus R Cancer J; 2001; 7 Suppl 2():S53-61. PubMed ID: 11777265 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cells for specific cancer immunotherapy. Meidenbauer N; Andreesen R; Mackensen A Biol Chem; 2001 Apr; 382(4):507-20. PubMed ID: 11405216 [TBL] [Abstract][Full Text] [Related]
8. [Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer]. Punt CJ; de Vries IJ; Mulders PF; Adema GJ; Figdor CG Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2408-14. PubMed ID: 10608974 [TBL] [Abstract][Full Text] [Related]
9. Dendritic cells in cancer immunotherapy. Gunzer M; Grabbe S Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600 [TBL] [Abstract][Full Text] [Related]
10. Advances in specific immunotherapy for prostate cancer. Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335 [TBL] [Abstract][Full Text] [Related]
15. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines. Ruffini PA; Neelapu SS; Kwak LW; Biragyn A Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation. Van Nuffel AM; Corthals J; Neyns B; Heirman C; Thielemans K; Bonehill A Methods Mol Biol; 2010; 629():405-52. PubMed ID: 20387165 [TBL] [Abstract][Full Text] [Related]
17. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. Klippstein R; Pozo D Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824 [TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with dendritic cells for cancer. Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway. Delcayre A; Shu H; Le Pecq JB Expert Rev Anticancer Ther; 2005 Jun; 5(3):537-47. PubMed ID: 16001959 [TBL] [Abstract][Full Text] [Related]
20. Dendritic cells in cancer immunotherapy - a short review. Wojas K; Tabarkiewicz J; Roliński J Folia Morphol (Warsz); 2003 Nov; 62(4):317-8. PubMed ID: 14655109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]